Eti-cel showed an 88% ORR and 63% CR (n=8) at current dose level in r/r NHL after ≥2 prior lines of therapyIn vivo data suggest IL-2 may further enhance response rates and optimize eti-cel expansion ...

Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss disorders, today ...

Data from Ahmedabad’s Civil Hospital, which is the largest in Gujarat, showed antimicrobial resistance to almost 80% drugs ...

Nature boasts incredible survivors capable of enduring extreme conditions, from scorching heat and freezing cold to nuclear ...

SHANGHAI and NANJING, China and PLEASANTON, Calif., Dec. 8, 2025 /PRNewswire/ -- IASO Biotechnology ('IASO Bio'), a commercial-stage biopharmaceutical company focused on the discovery, development, ...

The U.S. Department of Energy last week launched a sweeping set of initiatives aimed at reshaping the nation’s mineral supply chains, accelerating long-stalled permitting reforms, and advancing ...

Union Minister of State for Science and Technology and Earth Sciences, Dr Jitendra Singh, on Sunday described start-ups as key drivers of India’s growth, also underlining that mentorship, and not ...

Gilead and Arcellx reported promising data for their CAR-T therapy anito-cel at the annual American Society of Hematology ...

Shares of biotechnology firm Arcus Biosciences are presenting investors with a contradictory set of signals. While the stock price recently climbed to a 52-w ...

While duplicating Fido isn’t quite the ethical minefield that duplicating Uncle Fred would be, it does raise questions on ...

Wake Tech celebrated the “Best Day Ever” on Saturday, hosting its largest fall commencement ceremony in history and honoring ...

Biotechnology leader Biocon is fully integrating Biocon Biologics, valuing it at $5.5 billion. The merger involves share ...